Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CANCNASDAQ:MAGXNASDAQ:RCGENASDAQ:VOLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$25.09+0.8%$24.41$20.10▼$30.11$67.99M1.119,660 shs21,068 shsMAGXRoundhill Daily 2X Long Magnificent Seven ETF$42.77+2.0%$36.43$22.41▼$53.81$81.26M3.39137,978 shs95,342 shsRCGERockCreek Global Equality ETF$26.67+0.4%$25.80$21.98▼$26.67$82.68MN/A921,533 shs6 shsVOLTTema Electrification ETF$25.33+1.1%$23.48$19.00▼$27.46$76.75MN/A44,869 shs17,110 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF0.00%+2.30%+4.67%+3.96%-7.01%MAGXRoundhill Daily 2X Long Magnificent Seven ETF0.00%+9.92%+11.18%+36.82%+23.97%RCGERockCreek Global Equality ETF0.00%+2.82%+2.07%+7.85%+2,667,139,900.00%VOLTTema Electrification ETF0.00%+3.56%+6.83%+18.81%+2,532,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AN/AN/AN/AN/ARCGERockCreek Global Equality ETFN/AN/AN/AN/AN/AN/AN/AN/AVOLTTema Electrification ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETF 2.80Moderate Buy$25.09N/AMAGXRoundhill Daily 2X Long Magnificent Seven ETF 0.00N/AN/AN/ARCGERockCreek Global Equality ETF 2.76Moderate Buy$26.67N/AVOLTTema Electrification ETF 2.74Moderate Buy$25.33N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AN/AN/ARCGERockCreek Global Equality ETFN/AN/AN/AN/AN/AN/AVOLTTema Electrification ETF$894.36M0.09N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A22.39∞N/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/A0.00∞N/AN/AN/AN/AN/ARCGERockCreek Global Equality ETFN/AN/A16.94∞N/AN/AN/AN/AN/AVOLTTema Electrification ETFN/A$0.11230.27∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.722.87%N/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETF$0.390.91%N/AN/AN/ARCGERockCreek Global Equality ETFN/AN/AN/AN/AN/AVOLTTema Electrification ETFN/A0.01%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/ARCGERockCreek Global Equality ETFN/AVOLTTema Electrification ETF33.60%Insider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/ARCGERockCreek Global Equality ETFN/AVOLTTema Electrification ETF10.38%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A2.71 millionN/ANot OptionableMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/A1.90 millionN/AN/ARCGERockCreek Global Equality ETFN/A3.10 millionN/AN/AVOLTTema Electrification ETFN/A3.03 millionN/AN/ARCGE, MAGX, VOLT, and CANC HeadlinesRecent News About These CompaniesTema Electrification ETF (VOLT) Related Fund Growth, Competitive Fund Growth - Seeking AlphaJune 26, 2025 | seekingalpha.comVoltage Metals Corp. Announces Completion of Option Agreement with Plethora Green EnergyMay 27, 2025 | newsfilecorp.comNTema Electrification ETF (VOLT)February 2, 2025 | investing.comVOLT Tema Electrification ETFJanuary 23, 2025 | seekingalpha.comTema Electrification Etf Share Price (VOLT.US)December 10, 2024 | lse.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRCGE, MAGX, VOLT, and CANC Company DescriptionsTema Oncology ETF NASDAQ:CANC$25.09 +0.19 (+0.76%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$24.78 -0.31 (-1.24%) As of 06/27/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Roundhill Daily 2X Long Magnificent Seven ETF NASDAQ:MAGX$42.77 +0.83 (+1.98%) As of 06/27/2025 04:00 PM EasternThe Roundhill Daily 2X Long Magnificent Seven ETF (MAGX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund-of-funds aiming to achieve 2x the return, for a single day, of the Roundhill Magnificent Seven ETF (MAGS) through derivative instruments such as swaps. MAGX was launched on Feb 29, 2024 and is issued by Roundhill.RockCreek Global Equality ETF NASDAQ:RCGE$26.67 +0.11 (+0.41%) As of 06/27/2025The RockCreek Global Equality ETF (RCGE) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively managed fund of equities from developed and emerging markets, focused on firms committed to gender-balance within its company, also filtered through a fundamental screen. RCGE was launched on Feb 27, 2025 and is issued by RockCreek.Tema Electrification ETF NASDAQ:VOLT$25.33 +0.27 (+1.08%) As of 06/27/2025 04:00 PM EasternThe Tema Electrification ETF (VOLT) is an exchange-traded fund that mostly invests in utilities equity. The fund actively invests in a concentrated portfolio of companies worldwide that are positioned to benefit from the electrification megacycle. The fund seeks long-term growth of capital. VOLT was launched on Dec 3, 2024 and is issued by Tema. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
